Flagship Biosciences, Inc. — Form D

Flagship Biosciences, Inc. of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-09. The offering totals $15.3M, of which $15.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Fisher AaronDirectorBroomfield, CO
Herb H HooperDirectorBroomfield, CO
Bill H SniderDirectorBroomfield, CO
Tom H TuriDirectorBroomfield, CO
William SniderDirectorBethesda, MD
Paul KirchgraberDirectorBroomfield, CO
Trevor JohnsonDirectorBroomfield, CO
Trevor JohnsonExecutive OfficerBroomfield, CO
Trevor JohnsonPromoterBroomfield, CO
Tom TuriDirectorBroomfield, CO
Tom TuriExecutive OfficerBroomfield, CO
Herb HooperDirectorBroomfield, CO
Joe Dean KrugerExecutive OfficerWestminster, CO
Nancy Dean GillettDirectorWestminster, CO
G. David YoungDirectorWestminster, CO
G. David YoungExecutive OfficerWestminster, CO
G. David YoungPromoterWestminster, CO
Gary Dean ClarkDirectorWestminster, CO
L. Dean NortheyExecutive OfficerWestminster, CO
Holger Dean LangeExecutive OfficerWestminster, CO
Dean David NortheyExecutive OfficerWestminster, CO
Nancy A GillettDirectorWestminster, CO
Gary M ClarkDirectorWestminster, CO
Gregory K TuckerDirectorWestminster, CO

Other filings by this issuer (5)

FiledFormOfferingSold
2024-04-18D$6.4M$5.0M
2024-02-21D/A$5.0M$3.0M
2023-12-14D$1.5M$1.5M
2018-07-09D$2.5M$2.5M
2018-03-16D$1.0M$1.0M

More